Zhongfan Zhang

Rivaroxaban in heart failure patients with left ventricular thrombus: A retrospective study

D. Si, P. Yang, Wenqi Zhang, 2022, Frontiers in Pharmacology.

Rivaroxaban versus Vitamin K Antagonists (warfarin) based on the triple therapy for left ventricular thrombus after ST-Elevation myocardial infarction

Ping Yang, Miao Yu, D. Si, 2021, Heart and Vessels.

Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus After Anterior ST-Segment Elevation Myocardial Infarction.

Yuquan He, Ping Yang, Miao Yu, 2022, JACC. Cardiovascular interventions.

Clinical profile and prognosis of elderly patients with left ventricular thrombus after anticoagulation

D. Si, Wenqi Zhang, Miao Yu, 2023, Thrombosis Journal.

Silencing of UTX Mitigates Aging-Associated Cardiac Fibrosis via Blocking Cardiac Fibroblasts-to-Myofibroblasts Trans-Differentiation

C. Li, Tiantian Lin, Kaiyao Shi, 2023, Anatolian journal of cardiology.

Silencing of UTX Mitigates Aging-Associated Cardiac Fibrosis via Blocking Cardiac Fibro blasts-to- Myofi brobl asts Trans-Differentiation

Tiantian Lin, Zhongfan Zhang, Delin Li, 2023 .

Rivaroxaban, a direct inhibitor of coagulation factor Xa, attenuates adverse cardiac remodeling in rats by regulating the PAR-2 and TGF-β1 signaling pathways

Wenqi Zhang, Zhongfan Zhang, Qian Zhang, 2023, PeerJ.